Jeet Mahal
2023
In 2023, Jeet Mahal earned a total compensation of $1.2M as Chief Operating Officer at Jasper Therapeutics, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,024 |
|---|---|
| Option Awards | $535,990 |
| Salary | $461,693 |
| Total | $1,184,707 |
Mahal received $536K in option awards, accounting for 45% of the total pay in 2023.
Mahal also received $187K in non-equity incentive plan and $461.7K in salary.
Rankings
In 2023, Jeet Mahal's compensation ranked 1,015th out of 2,918 executives tracked by ExecPay. In other words, Mahal earned more than 65.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,015 out of 2,918 | 65th |
Division Manufacturing | 609 out of 1,608 | 62nd |
Major group Chemicals And Allied Products | 419 out of 901 | 54th |
Industry group Drugs | 408 out of 864 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 122 out of 211 | 42nd |
Source: SEC filing on April 22, 2024.
Mahal's colleagues
We found three more compensation records of executives who worked with Jeet Mahal at Jasper Therapeutics in 2023.